Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia

DOI Web Site 5 Citations

Jennifer G. Robinson

Department of Epidemiology, College of Public Health, University of Iowa, Iowa City2Department of Medicine, College of Public Health, University of Iowa, Iowa City
Bettina S. Nedergaard

Center for Clinical and Basic Research, Aalborg, Denmark
William J. Rogers

Division of Cardiovascular Disease, University of Alabama Medical Center, Birmingham
Jonathan Fialkow

Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami
Joel M. Neutel

Orange County Research Center, Tustin, California
David Ramstad

Hampton Roads Center for Clinical Research, Suffolk, Virginia
Ransi Somaratne

Amgen Inc, Thousand Oaks, California
Jason C. Legg

Amgen Inc, Thousand Oaks, California
Patric Nelson

Amgen Inc, Thousand Oaks, California
Rob Scott

Amgen Inc, Thousand Oaks, California
Scott M. Wasserman

Amgen Inc, Thousand Oaks, California
Robert Weiss

Maine Research Associates, Auburn

Bibliographic Information

Other Title

Back to top